Rapid Immunoassay for the Direct Detection of SARS-Cov-2 Antigen for use with anterior nasal specimens for at home use.
FDA Emergency Use Authorization (EUA)
For Home Use, Workplace Testing, Schools
Ages 14 years and older
Ages 2 years and younger when specimen collected and tested by an adult.